Isodose Control Overview

  • Founded
  • 2003

  • Status
  • Acquired/​Merged

  • Employees
  • 4

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Isodose Control General Information


Operator of a medical technology company. The company is engaged in the development of brachytherapy products for the treatment of cancer. It also offers radiation therapy for cancer patients.

Contact Information

Ownership Status
Financing Status
Private Equity-Backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Hospitals/Inpatient Services
Other Healthcare Technology Systems
Primary Office
  • PO Box 615
  • 3900 Veenendaal
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Isodose Control Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Isodose Control‘s full profile, request access.

Request a free trial

Isodose Control Executive Team (1)

Name Title Board Seat Contact Info
Reinier vant Hooft Chief Executive Officer & Co-Founder
To view Isodose Control’s complete executive team members history, request access »

Isodose Control Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial